CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer

CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer

GiantsOfCancerCare

4 years
499 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Hope S. Rugo, MD of the UCSF Medical Center discusses the state of CDK 4/6 Inhibitors for Patients with HR+/HER- Breast Cancer
Up Next Autoplay